Orakl Oncology Raises $34 Million for AI Drug Prediction
Orakl Oncology raised an oversubscribed $34 million Series A, bringing total funding to $50 million. It will scale organoid data generation and predictions across more than 10 drug programs.
Topic
AI Drug Discovery
Topic
AI Drug Discovery
Sanyou Bio Raises Nearly $15M to Scale AI Drug Discovery
Sanyou Bio raised nearly $15 million in an exclusive Series C backed by Zero2IPO Industry Investment, funding an 11-trillion-cand…
Fathom Therapeutics Closes $55M Series A to Push AI Drug Discovery
Fathom Therapeutics raised an oversubscribed $55M Series A led by Sutter Hill Ventures, with Kos BioVentures joining to scale its…
Laboratoires Pierre Fabre and XtalPi strike AI drug deal
November 9, 2026: Laboratoires Pierre Fabre and XtalPi announced a multi-program drug-discovery deal combining AI-designed molecu…
QUANTRO Therapeutics Secures 12-Month AI Drug Discovery Grant
QUANTRO Therapeutics secured a 12-month, non-dilutive Austrian research grant to expand ASCEND, its AI-powered drug-discovery pla…
Venomics AI Raises $2.7 Mn Pre-Seed to Turn Venom Into Drugs
IISc spinout Venomics AI has raised $2.7 million in a pre-seed round co-led by Speciale Invest and South Park Commons to build it…
Anthropic Buys One-Employee Drug Startup Ahead of Possible IPO
Anthropic bought Mithril Medicine, a one-employee biotech where founder Cody Tranbarger used Claude to run 11 labs and reach mous…
Iambic Banks $150 Million in IPO as AI Drug Discovery Heats Up
AI drug discovery company Iambic raised $150 million in its IPO, BioPharma Dive reports, handing the computational biotech fresh…
Alphabet's Isomorphic Labs Targets $40 Billion Valuation in New Round
Isomorphic Labs, Alphabet's drug-discovery company, is seeking a valuation of at least $40 billion in a new funding round, accord…
Basecamp Research Raises $140M Series C Led by S32
S32 led the oversubscribed round, with Anthropic's Anthology Fund and NVIDIA participating. The funds will train new EDEN models…
AI Drug Developer Basecamp Hits $800 Million Valuation
AI-based drug developer Basecamp raised $140 million and is now valued at $800 million, The Economic Times reports, placing the f…